Rating History for Novus Therapeutics, Inc (NVUS) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/10/2020 | N/A | New Coverage | Buy (N/A) |
43.00 (N/A) |
19.79 (14.60) |
-26.23% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/10/2020 | N/A | New Coverage | Buy (N/A) |
43.00 (N/A) |
19.79 (14.60) |
-26.23% | Details |
![]() |
|||||||
![]() |
|||||||